Augusta University is a public research university and academic medical center in Augusta, Georgia. It is a part of the University System of Georgia and has satellite medical campuses in Savannah, Albany, Rome, and Athens.

During the past decade, Augusta University conducted 222 clinical trials. In the 10-year time frame, 222 clinical trials started and 144 clinical trials were completed, i.e. on average, 64.9% percent of trials that started reached the finish line to date. In the past 5 years, 82 clinical trials started and 75 clinical trials were completed. i.e. 91.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Augusta University" #1 sponsor was "Augusta University" with 66 trials, followed by "Novartis Pharmaceuticals" with 18 trials sponsored, "Bristol-Myers Squibb" with 13 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials sponsored and "Gilead Sciences" with 13 trials sponsored. Other sponsors include 346 different institutions and companies that sponsored additional 229 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta University" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 16 trials as a collaborator, "Augusta University" with 13 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 11 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 9 trials as a collaborator. Other collaborators include 300 different institutions and companies that were collaborators in the rest 200 trials.

According to Clinical.Site data, the most researched conditions in "Augusta University" are "HIV Infections" (23 trials), "Schizophrenia" (15 trials), "Sickle Cell Disease" (15 trials), "Cystic Fibrosis" (12 trials) and "Amyotrophic Lateral Sclerosis" (11 trials). Many other conditions were trialed in "Augusta University" in a lesser frequency.

Most popular intervention types in "Augusta University" are "Drug" (323 trials), "Other" (64 trials), "Biological" (36 trials), "Device" (36 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (99 trials), "placebo" (11 trials), "Fluconazole" (8 trials), "Carboplatin" (5 trials) and "Indoximod" (5 trials). Other intervention names were less common.

The vast majority of trials in "Augusta University" are 400 trials for "All" genders, 66 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Augusta University". 3 are not yet recruiting, 52 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 291 completed trials in Augusta University, undefined suspended trials, and 55 terminated clinical trials to date.

Out of the total trials that were conducted in Augusta University, 41 "Phase 1" clinical trials were conducted, 147 "Phase 2" clinical trials and 149 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 64 trials that are defined as “Not Applicable".

Augusta University has several departments that took part in Clinical trials: "MBCCOP - Medical College of Georgia Cancer Center" - 162 trials, "Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases" - 6 trials, "Augusta University-Dental College of Georgia" - 5 trials, "Medical College of Georgia - Department of Neurology" - 2 trials, "Augusta University Department of Otolaryngology-Head and Neck Surgery" - 2 trials